BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18639553)

  • 21. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
    Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
    Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifactorial relationship between 18F-fluoro-deoxy-glucose positron emission tomography signaling and biomechanical properties in unruptured aortic aneurysms.
    Nchimi A; Cheramy-Bien JP; Gasser TC; Namur G; Gomez P; Seidel L; Albert A; Defraigne JO; Labropoulos N; Sakalihasan N
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):82-91. PubMed ID: 24190906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
    Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
    Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].
    Ruiz Hernández G; Romero de Avila Y Avalos C; Carreras Delgado JL
    Med Clin (Barc); 2005 Feb; 124(6):229-36. PubMed ID: 15737307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106.
    Cuhlmann S; Gsell W; Van der Heiden K; Habib J; Tremoleda JL; Khalil M; Turkheimer F; Meens MJ; Kwak BR; Bird J; Davenport AP; Clark J; Haskard D; Krams R; Jones H; Evans PC
    Mol Imaging; 2014; 13():. PubMed ID: 24825602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Structural Stress and Presence of Intraluminal Thrombus Predict Abdominal Aortic Aneurysm 18F-FDG Uptake: Insights From Biomechanics.
    Huang Y; Teng Z; Elkhawad M; Tarkin JM; Joshi N; Boyle JR; Buscombe JR; Fryer TD; Zhang Y; Park AY; Wilkinson IB; Newby DE; Gillard JH; Rudd JH
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):e004656. PubMed ID: 27903534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
    Moadel RM; Nguyen AV; Lin EY; Lu P; Mani J; Blaufox MD; Pollard JW; Dadachova E
    Breast Cancer Res; 2003; 5(6):R199-205. PubMed ID: 14580255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
    Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
    Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
    Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
    Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Serizawa M; Koh Y; Hanaoka H; Tominaga H; Oriuchi N; Kondo H; Nakajima T; Yamamoto N
    J Clin Oncol; 2010 Aug; 28(23):3746-53. PubMed ID: 20625125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
    Cullinane C; Dorow DS; Jackson S; Solomon B; Bogatyreva E; Binns D; Young R; Arango ME; Christensen JG; McArthur GA; Hicks RJ
    J Nucl Med; 2011 Aug; 52(8):1261-7. PubMed ID: 21764800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous flushing of the bladder in rodents reduces artifacts and improves quantification in molecular imaging.
    Deleye S; Heylen M; Deiteren A; De Man J; Stroobants S; De Winter B; Staelens S
    Mol Imaging; 2014; 13():. PubMed ID: 24825484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
    Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
    Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography and single photon emission computed tomography imaging of tertiary lymphoid structures during the development of lupus nephritis.
    Dorraji ES; Oteiza A; Kuttner S; Martin-Armas M; Kanapathippillai P; Garbarino S; Kalda G; Scussolini M; Piana M; Fenton KA
    Int J Immunopathol Pharmacol; 2021; 35():20587384211033683. PubMed ID: 34344200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression.
    Zhao C; Wang D; Wu M; Luo Y; Yang M; Guo J; Zhang H; Zhang X
    J Int Med Res; 2020 Jun; 48(6):300060520926011. PubMed ID: 32567429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
    Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
    Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.